International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
In 2021, SNOMED International and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) announced the release of important new maps between global medical terminologies SNOMED CT and MedDRA. This collaborative effort was the first deliverable of a new agreement entered into between SNOMED International and ICH.
This joint effort has produced two independent maps (MedDRA to SNOMED CT and SNOMED CT to MedDRA) of a priority set of MedDRA content which have been derived from frequently used and key pharmacovigilance MedDRA terms identified from the European Medicines Agency and the UK’s Medicines & Healthcare products Regulatory Agency. In addition, a set of COVID-19 related terms are also included in the first production release of the maps to capture important aspects of the pandemic.
The two maps were created as part of a project involving SNOMED International and ICH entitled WEB-RADR 2. Funded by the Innovative Medicines Initiative (IMI), a large-scale public-private partnership between the EU and the pharmaceutical industry association, EFPIA, IMI aims to boost biopharmaceutical innovation in Europe and to speed up the development of better and safer medicines for patients. With the creation of the maps from the WEB-RADR 2 project, both SNOMED International and ICH have committed to their ongoing use and maintenance extending past the conclusion of the project.
The 2 maps were first released in April 2021 - in RF2 format by SNOMED International and human readable format by MedDRA MSSO (acting on behalf of ICH). The maps are maintained, updated and released annually with a change request mechanism available through MedDRA MSSO.